Hussman Strategic Advisors, Inc. Voyager Therapeutics, Inc. Transaction History
Hussman Strategic Advisors, Inc.
- $351 Million
- Q2 2024
A detailed history of Hussman Strategic Advisors, Inc. transactions in Voyager Therapeutics, Inc. stock. As of the latest transaction made, Hussman Strategic Advisors, Inc. holds 52,500 shares of VYGR stock, worth $307,125. This represents 0.12% of its overall portfolio holdings.
Number of Shares
52,500
Previous 52,500
-0.0%
Holding current value
$307,125
Previous $488,000
14.96%
% of portfolio
0.12%
Previous 0.12%
Shares
1 transactions
Others Institutions Holding VYGR
# of Institutions
128Shares Held
36.7MCall Options Held
48KPut Options Held
36.2K-
Black Rock Inc. New York, NY5.31MShares$31.1 Million0.0% of portfolio
-
Armistice Capital, LLC New York, NY5.2MShares$30.4 Million0.54% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA3.92MShares$22.9 Million1.1% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.04MShares$17.8 Million0.0% of portfolio
-
Farallon Capital Management LLC San Francisco, CA2.29MShares$13.4 Million0.09% of portfolio
About Voyager Therapeutics, Inc.
- Ticker VYGR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 38,647,600
- Market Cap $226M
- Description
- Voyager Therapeutics, Inc., a gene therapy company, focuses on the development of treatments and next-generation platform technologies. The company's lead clinical candidate is the VY-AADC, which is in open-label Phase 1 clinical trial for the treatment of Parkinson's disease. Its preclinical programs comprise VY-SOD102 for the treatment of amyo...